Patent intelligence · US
US 11478425
Extended release compositions comprising pyridostigmine
Extended release compositions comprising pyridostigmine
Patent details — US 11478425
- Jurisdiction
- US
- Status
- granted
- Grant date
- Oct 25, 2022
- Expiration
- Oct 20, 2042
- Applicant
- Amneal Complex Products Research LLC
- Claims
- 13
- CPC classes
- A61K, A61K31/4425, A61K9/0065, A61K9/1676
Quick answer
US 11478425 (Extended release compositions comprising pyridostigmine) is held by Amneal Complex Products Research LLC. Status: granted. Granted Oct 25, 2022. Expires Oct 20, 2042 (16 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- Amneal Complex Products Research LLC
- Grant date
- Expiration
- Claims
- 13
- CPC classes
- A61K, A61K31/4425, A61K9/0065, A61K9/1676, A61K9/2009, A61K9/2013
More from Amneal Complex Products Research LLC
Related pharmaceutical patents in our USPTO index.
-
US 12383522
Baclofen formulations and methods of minimizing patient exposure to metabolite variations
granted -
US 12370163
Levodopa dosing regimen
granted -
US 12303482
Levodopa dosing regimen
granted -
US 12303481
Levodopa dosing regimen
granted -
US 12295931
Levodopa dosing regimen
granted -
US 12263149
Levodopa dosing regimen
granted -
US 12263148
Levodopa dosing regimen
granted -
US 12233166
Extended release compositions comprising pyridostigmine
granted
Frequently asked questions
What is US patent 11478425?
US 11478425 (Extended release compositions comprising pyridostigmine) is held by Amneal Complex Products Research LLC. Status: granted. Granted Oct 25, 2022. Expires Oct 20, 2042 (16 years remaining) — relevant for patent-cliff and LOE planning.
Who owns US 11478425?
Amneal Complex Products Research LLC is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 32 pharmaceutical patents for this assignee.
When does US 11478425 expire?
Our index shows an expiration date of Oct 20, 2042 (16 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.